bpc-157 clinical trial dosing protocol human BPC-157 Dosing (Common Protocols) 🔹 Oral / Subcutaneous • 500 mcg daily • Duration: 6 weeks 🔹 Intramuscular / Peritendinous • 1 mg daily • Duration: 6 weeks ⚠️ Note: Not approved BPC-157 (5mg Vial) Dosage Protocol
Description
It is a synthetic fragment derived from a protein found in human gastric juice, where researchers originally studied it for its protective effects on the gastrointestinal lining
Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R, Feathers RW, Chu H, Lima H, Fellermann K, Ganz T, Stange EF, Bevins CL: Reduced Paneth cell -defensins in ileal Crohn's disease
Errors during reconstitution or storage directly impact effectiveness and safety
Less PRP means less growth factors, which can mean your results may not be as good as they could have been
